NCT05727852Enrolling by invitation
Breath Analysis and Arterial Stiffness in Patients With Respiratory Diseases
Exhaled Breath Proton Mass Spectrometry and Assessment of Endothelial Dysfunction in Patients With Respiratory Diseases
Source: ClinicalTrials.gov · Last updated 30 Jul 2024 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
Assessment of cardiovascular disorders using echocardiography and arterial stiffness; comparative noninvasive assessment of volatile organic compound (eVOC) exhale breath patterns in patients with different chronic respiratory diseases with age and gender-matched healthy adults in order to identify a disease-specific exhaled eVOCs profiles and markers of respiratory and cardiovascular disorders.
- Status (registry)
- Enrolling by invitation
- Study type
- Observational
- Enrollment
- 400 (estimated)
- First submitted
- 6 Feb 2023
- Start date
- 30 Jan 2023
- Primary completion date
- Jan 2025
- Lead sponsor
- I.M. Sechenov First Moscow State Medical University
- Diseases
- Cystic fibrosis, Asthma, COPD
- NCT number
- NCT05727852
What you commit to
- Study type: Observational
- Planned participants: 400
- From 30 Jan 2023 to the primary completion date, Jan 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Previous lung transplantation (for patients with respiratory diseases);
Other illness
- Respiratory disease (for controls);
- Mental illness (severe dementia, schizophrenia, severe depression, manic-depressive psychosis);
- Acute coronary syndrome, acute cerebrovascular accident, pulmonary embolism within the last 3 months;
- Diseases and conditions that can change the ECG picture and complicate the analysis of the ECG (conduction disturbance, pacemaker);
- Inability to use a heart monitor (congenital developmental anomalies, traumatic amputation of the upper limbs, essential tremor, Parkinson's disease);
Other
- Unable to sign informed consent;
- Oncology;
- Pregnancy.
Who the study is looking for
- Written informed consent to participate in the study;
- Age 18 and over;
- Clinical diagnosis of one of chronic respiratory diseases (COPD, bronchial asthma, cystic fibrosis, lymphangioleiomyomatosis, hypersensitivity pneumonitis or other interstitial lung disease).
Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| I.M. Sechenov First Moscow State Medical University (Sechenov University), Center "Digital biodesign and personalized healthcare" Coordinator of this site? Confirm its status | Moscow | Russia | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.